AlloVir (NASDAQ:ALVR) Target Raised by Morgan Stanley to $48.00

StockMarketDaily.co reports: AlloVir stock has undergone multiple analysts rating changes in the recent past.  AlloVir stock Target Raised by   Morgan Stanley on 10/12/2021. In a note to investors, the firm issued a new target price of $48.00. The analysts previously had $47.00 target price.

View More AlloVir (NASDAQ:ALVR) Target Raised by Morgan Stanley to $48.00